Electrolyte Emergencies on ECG: Hypo- and Hypercalcemia

Electrolyte disturbances are among the most common correctable causes of life-threatening arrhythmias. While potassium changes are usually covered in detail in ECG courses, calcium and magnesium disturbances often remain in the shadows – unjustly so. Severe hypocalcemia can trigger treatment-resistant heart failure, hypercalcemia can drive the heart into asystole, and hypomagnesemia can precipitate the dreaded Torsade de Pointes. In an emergency situation, your ability to read the ECG determines whether you recognize these derangements early and treat them appropriately. This article systematically guides you through the ECG changes in hypo- and hypercalcemia as well as hypomagnesemia, explains the pathophysiological mechanisms, and provides you with concrete treatment algorithms for clinical practice.

Calcium and the Cardiac Action Potential

To understand the ECG changes in calcium disturbances, a brief look at electrophysiology is worthwhile. Ionized calcium (Ca²⁺) plays a central role in Phase 2 of the cardiac action potential – the so-called plateau phase. Ca²⁺ enters the myocytes through L-type calcium channels, maintains the membrane potential at the plateau, and simultaneously initiates electromechanical coupling.

The QT Interval as the Key Parameter

On the surface ECG, the plateau phase is primarily reflected in the ST segment. The duration of the entire action potential is mirrored in the QT interval. This leads to an elegant rule of thumb:

• Hypocalcemia → prolonged plateau phase → prolonged QT interval (primarily through prolongation of the ST segment)
• Hypercalcemia → shortened plateau phase → shortened QT interval (primarily through shortening of the ST segment)

The crucial difference from potassium disturbances: While potassium primarily alters T-wave morphology, calcium primarily affects the ST segment between the end of the QRS and the beginning of the T wave. The T wave itself remains largely unchanged in isolated calcium disturbances – an important clue for differential diagnosis.

Reference Values and Clinical Relevance

For interpreting ECG changes, ionized calcium (iCa²⁺) is what matters, not total calcium:

• Normal range ionized calcium: 1.15–1.30 mmol/L
• Hypocalcemia: iCa²⁺ < 1.15 mmol/L (severe: < 0.9 mmol/L)
• Hypercalcemia: iCa²⁺ > 1.30 mmol/L (severe: > 1.6 mmol/L)

Keep in mind: A normal total calcium does not rule out significant hypocalcemia in patients with hypoalbuminemia (ICU patients, sepsis, liver cirrhosis). When in doubt, always use the ionized calcium from the blood gas analysis.

Hypocalcemia: ECG Patterns and Clinical Presentation

Typical ECG Changes

The hallmark of hypocalcemia on ECG is QTc prolongation due to ST segment prolongation. In detail:

• Prolonged ST segment: The interval between the end of the QRS complex (J-point) and the beginning of the T wave is noticeably stretched. The T wave starts late but remains morphologically normal.
• QTc prolongation: Usually > 500 ms in severe hypocalcemia. The prolongation roughly correlates with the severity of the calcium deficit.
• U waves: Occasionally visible, especially with concurrent hypokalemia or hypomagnesemia.
• ST depression and T-wave flattening: Possible in severe hypocalcemia, potentially mimicking an ischemic pattern.

Practical tip for differentiation: When you see a prolonged QT interval, pay close attention to where the prolongation is. In hypocalcemia, the ST segment between the J-point and the T-wave upstroke is prolonged – the T wave itself has a normal duration. In hypokalemia, by contrast, the T wave is flat or broad, and a U wave merges with it. This distinction helps you target the correct electrolyte disturbance.

Arrhythmia Potential

The QT prolongation in hypocalcemia increases the risk of:

• Torsade de Pointes (TdP): Polymorphic ventricular tachycardia on the basis of a prolonged QT interval
• Ventricular tachycardia / ventricular fibrillation: Less common than with potassium disturbances, but relevant when combined with other QT-prolonging factors (medications, hypokalemia, hypomagnesemia)
• Bradycardia and AV blocks: Described in severe hypocalcemia

Common Causes in Emergency Medicine

• Massive blood transfusion (citrate binds ionized calcium)
• Sepsis and septic shock
• Pancreatitis
• Hypoparathyroidism (postoperative after thyroid/parathyroid surgery)
• Vitamin D deficiency
• Rhabdomyolysis (hyperphosphatemia → calcium complexation)
• Medications (bisphosphonates, loop diuretics, foscarnet)

Emergency Treatment of Severe Hypocalcemia

For symptomatic or severe hypocalcemia (iCa²⁺ < 0.9 mmol/L) with ECG changes:

1. Calcium gluconate 10% – 10–20 mL (1–2 g) IV over 10–20 minutes – first-line agent due to better venous tolerability
2. Alternatively calcium chloride 10% – 5–10 mL (500–1000 mg) IV over 5–10 minutes – three times higher calcium concentration, therefore preferred during resuscitation or via central venous catheter
3. Monitoring: Continuous ECG monitoring, check ionized calcium after 15–30 minutes
4. Repeat as needed, consider continuous infusion: Calcium gluconate 10% 100 mL in 1000 mL NaCl 0.9% over 8–12 hours
5. Correct magnesium: Hypomagnesemia renders hypocalcemia refractory to treatment – Magnesium sulfate 2 g IV over 15 minutes

Caution with digitalis preparations: Calcium potentiates digitalis toxicity. In digitalized patients, administer calcium slowly and under close monitoring.

Hypercalcemia: ECG Patterns and Clinical Presentation

Typical ECG Changes

Hypercalcemia shortens the plateau phase and thus produces mirror-image changes compared to hypocalcemia:

• Shortened QTc interval: Often < 360 ms, in severe hypercalcemia < 300 ms. The ST segment is virtually absent – the T wave appears to arise directly from the QRS complex.
• Shortened to absent ST segment: The J-point transitions seamlessly into the upstroke of the T wave.
• Widened T wave: In severe hypercalcemia, the T wave can become broad-based and prominent.
• QRS widening: Possible at iCa²⁺ > 2.0 mmol/L, a sign of severe myocardial toxicity.
• Osborn wave (J wave): Occasionally described in pronounced hypercalcemia.
• Arrhythmias: Bradycardia, AV blocks, asystole in extreme hypercalcemia.

Memory aid: "Short QT, short to live" – a markedly shortened QT interval should immediately make you think of severe hypercalcemia.

ECG Progression Signs

With rising calcium levels, a typical sequence emerges:

1. Mild hypercalcemia (iCa²⁺ 1.3–1.5 mmol/L): QTc shortening, often asymptomatic
2. Moderate hypercalcemia (iCa²⁺ 1.5–1.8 mmol/L): Marked ST shortening, T-wave changes, occasional sinus bradycardia
3. Severe hypercalcemia (iCa²⁺ > 1.8 mmol/L): QRS widening, high-grade bradycardia, AV blocks
4. Extreme hypercalcemia (iCa²⁺ > 2.5 mmol/L): Sine-wave pattern, asystole – immediately life-threatening

Common Causes

• Primary hyperparathyroidism
• Malignancies (bone metastases, paraneoplastic PTHrP secretion)
• Vitamin D intoxication
• Immobilization (in Paget's disease, after fractures)
• Granulomatous diseases (sarcoidosis, tuberculosis)
• Thiazide diuretics, lithium
• Milk-alkali syndrome

Emergency Treatment of Severe Hypercalcemia

For severe symptomatic hypercalcemia with ECG changes:

1. Volume expansion: NaCl 0.9% – 200–300 mL/h IV (target: urine output 200–300 mL/h), adjusted to cardiac tolerance
2. Loop diuretic: Furosemide 20–40 mg IV only after adequate hydration – not primarily for calcium lowering, but for volume overload
3. Calcitonin: 4 IU/kg body weight subcutaneously or intramuscularly every 12 hours – onset of action within 4–6 hours, the fastest pharmacological approach
4. Bisphosphonates: Zoledronic acid 4 mg IV over 15 minutes or pamidronate 60–90 mg IV over 2–4 hours – onset of action only after 2–4 days, but sustained
5. Glucocorticoids: For vitamin D-mediated hypercalcemia (sarcoidosis, lymphomas): Hydrocortisone 200 mg IV or prednisolone 40–60 mg IV
6. Hemodialysis: For treatment-refractory hypercalcemia, renal failure, or calcium levels > 4.5 mmol/L (total calcium)

Note for resuscitation: Hypercalcemia is not among the classic 5Hs/5Ts but is considered in the extended differential diagnosis of reversible causes. In bradycardia-related cardiac arrest with known hypercalcemia, aggressive volume resuscitation with isotonic saline is the priority.

Hypomagnesemia: The Silent Accomplice

Magnesium deserves special attention in this context because it acts as a co-factor in virtually every other electrolyte disturbance. Hypomagnesemia rarely occurs in isolation – it accompanies and amplifies both potassium and calcium disturbances.

ECG Changes in Hypomagnesemia

The ECG changes resemble those of hypokalemia and are often difficult to distinguish:

• QTc prolongation: Due to inhibition of repolarizing potassium currents
• ST depression: Nonspecific, often scooped
• T-wave flattening to T-wave inversion
• Prominent U waves
• PR prolongation: In severe hypomagnesemia
• QRS widening: Rare, only at very low levels

The Key Role in Torsade de Pointes

The clinically most important arrhythmia in hypomagnesemia is Torsade de Pointes (TdP). Magnesium is the treatment of choice for TdP – regardless of the magnesium level. This is a key ACLS algorithm point:

• Magnesium sulfate 2 g (8 mmol) IV over 2–5 minutes for pulseless TdP
• Magnesium sulfate 2 g IV over 15–20 minutes for TdP with a pulse
• May be repeated after 10–15 minutes
• Maintenance infusion: 1–2 g/h over 4–6 hours

When to Think of Hypomagnesemia?

• Treatment-refractory hypokalemia (magnesium is essential for renal potassium conservation)
• Treatment-refractory hypocalcemia (magnesium is necessary for PTH secretion and action)
• Refractory arrhythmias despite adequate electrolyte correction
• At-risk populations: alcohol abuse, loop diuretics, proton pump inhibitors, diarrhea, chemotherapy (cisplatin)

Remember: If potassium and calcium fail to rise despite adequate supplementation, always check magnesium.

Combined Electrolyte Disturbances: The Rule, Not the Exception

In clinical reality, electrolyte disturbances rarely occur in isolation. Common combinations and their ECG effects:

Combination	ECG Effect	Clinical Relevance
Hypocalcemia + Hypokalemia	Additive QT prolongation	Massively increased TdP risk
Hypocalcemia + Hypomagnesemia	QT prolongation, treatment-refractory hypocalcemia	Always correct magnesium first
Hypercalcemia + Hypokalemia	Opposing QT effects, digitalis sensitization	Increased digitalis toxicity risk
Hypokalemia + Hypomagnesemia	Pronounced QT prolongation, U waves	Classic combination with diuretic therapy

The rule of thumb for emergency situations is: Magnesium first, then potassium, then calcium – this sequence ensures that the corrections of the subsequent electrolytes are actually effective.

Systematic Approach: ECG-Based Differential Diagnosis

When you see an abnormal ECG and suspect an electrolyte disturbance, the following framework can help:

QT Prolongation

1. ST segment prolonged, T wave normal → Hypocalcemia
2. T wave flat/broad, U wave prominent → Hypokalemia
3. Both → Combined disturbance, check magnesium

QT Shortening

1. ST segment shortened/absent → Hypercalcemia
2. T wave peaked and tall → Hyperkalemia (possible in early phase)

Practical Algorithm for Suspected Electrolyte-Associated Arrhythmia

1. Obtain a 12-lead ECG and determine QTc (Bazett formula: QTc = QT/√RR)
2. Blood gas analysis with ionized calcium, potassium, magnesium – immediately available
3. Consider the clinical context: Medications, comorbidities, associated symptoms
4. Immediate empirical treatment for life-threatening arrhythmia:
   • TdP → Magnesium sulfate 2 g IV
   • Suspected hyperkalemia → Calcium gluconate 10% 10 mL IV as a membrane stabilizer
   • Suspected severe hypocalcemia with hemodynamic compromise → Calcium gluconate 10% 10–20 mL IV
5. Await blood gas results and initiate targeted correction
6. Always think about the underlying cause: Electrolyte correction alone is not enough – the underlying disorder must be identified and treated

Pitfalls and Pearls

• Short QT is often overlooked: While QT prolongation is actively sought in clinical practice, a shortened QT interval frequently goes unnoticed. Train your eye for it – a QTc < 360 ms should raise a red flag.
• Calcium gluconate vs. calcium chloride: 10 mL of calcium chloride 10% contains approximately 6.8 mmol Ca²⁺, while 10 mL of calcium gluconate 10% contains only approximately 2.3 mmol Ca²⁺. Calcium chloride does not need to be hepatically metabolized first but is a venous irritant – use only calcium gluconate through peripheral IV access.
• Magnesium as a "universal antiarrhythmic": In a resuscitation situation, magnesium sulfate 2 g IV is worth trying for any polymorphic VT, even when the magnesium level is unknown.
• ECG changes in hypercalcemia can mimic acute coronary syndrome: ST elevations have been described in severe hypercalcemia. Always consider the clinical context.

Practical Training

Reliable recognition of electrolyte-related ECG changes and rapid initiation of the correct treatment require regular training under realistic conditions. In the ACLS course from Simulation Tirol, you systematically practice rhythm analysis, differential diagnosis of reversible causes, and structured management of life-threatening arrhythmias – including the electrolyte emergencies that frequently make the critical difference in clinical practice. All information about course formats and dates can be found at www.simulationtirol.com.

---